-
-
July's reviewers of the month BJU Int. (IF 3.7) Pub Date : 2025-06-03
Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.
-
Prostate cancer: detection, treatment and follow-up BJU Int. (IF 3.7) Pub Date : 2025-06-03
Click on the article title to read more.
-
Bridging the evidence gap in gender‐affirming care: urgent research needs BJU Int. (IF 3.7) Pub Date : 2025-06-03
Isabella Dolendo, Lee Zhao, Rachel Bluebond‐Langner, Jennifer T. AngerGender‐affirming care has emerged as a critical component of healthcare, addressing the specific medical and psychosocial needs of transgender and non‐binary individuals. In this review article, we address what we see as the most pressing evidence gaps in the gender health literature: long‐term effects of pubertal blockers and gender‐affirming hormone therapy and the lack of standardised outcome measures
-
Chronic pelvic pain syndrome: the most common urological disease medicine chose to forget BJU Int. (IF 3.7) Pub Date : 2025-05-30
Datesh DaneshwarClick on the article title to read more.
-
Quartz sand as a phantom for urinary stone dust BJU Int. (IF 3.7) Pub Date : 2025-05-30
Bingyuan Yang, Aditi Ray, James Zhang, Ben TurneyThere is no universal consensus on which fragments can safely be left behind following ureteroscopy (if any). There is growing interest in achieving a true zero-fragment status in patients [1, 2] and this has led to the development of technologies such as suction ureteric access sheaths and direct in-scope suction [3]. This research demands a high-quality model for urinary stone dust. The most commonly
-
Residents surgical training using metrics for transurethral resection of bladder tumours BJU Int. (IF 3.7) Pub Date : 2025-05-29
Arturo Lo Giudice, Angelo De Stefano, Gabriele Sorce, Ettore Di TrapaniClick on the article title to read more.
-
Magnetic resonance imaging for long‐term active surveillance biopsy decision‐making BJU Int. (IF 3.7) Pub Date : 2025-05-29
Riccardo Leni, Amy L. Tin, Nicole Liso, Sigrid V. Carlsson, Oguz Akin, Francesco Montorsi, Alberto Briganti, James A. Eastham, Andrew J. Vickers, Behfar EhdaieObjectivesTo evaluate whether long‐term magnetic resonance imaging (MRI) findings, alone or in combination with prostate‐specific antigen (PSA) density or the result of prior surveillance biopsies, could be used to omit biopsies occurring after patients have been on active surveillance (AS) for ≥5 years.Patients and MethodsAnalysis of a single‐institution AS cohort of patients with Grade Group (GG)
-
Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic obstruction: 1‐year clinical outcomes of a phase II study BJU Int. (IF 3.7) Pub Date : 2025-05-28
Antti Viitala, Mikael Anttinen, Pietari Mäkelä, Heikki Pärssinen, Pertti Nurminen, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. BoströmObjectivesTo evaluate the safety and efficacy of magnetic resonance imaging (MRI)‐guided transurethral ultrasound ablation (TULSA) as a minimally invasive alternative for benign prostatic obstruction (BPO).Patients and MethodsThis prospective, single‐centre, early phase II study (NCT03350529) included 30 men with BPO scheduled for primary transurethral resection of the prostate. Assessments over 12
-
Response to Mehta et al. BJU Int. (IF 3.7) Pub Date : 2025-05-27
Caio V. SuartzClick on the article title to read more.
-
Empowering patient choice: a systematic review of decision aids for benign prostatic hyperplasia BJU Int. (IF 3.7) Pub Date : 2025-05-27
Charlotte Hollands, Debra Gray, Andrew Marren, Richard Hindley, Margaret HustedBackgroundBenign prostatic hyperplasia (BPH) is a complex condition that affects ~3.2 million men in the UK. As men often face multiple treatment options, discussion and consideration of their priorities and preferences is necessary; however, research indicates this is not always adopted in practice.ObjectivesTo evaluate decisional interventions currently available for men with symptomatic BPH, distinct
-
A comment on: ‘Comparing open and video endoscopic lymphadenectomy for penile cancer: a systematic review and meta‐analysis of prospective studies’ BJU Int. (IF 3.7) Pub Date : 2025-05-27
Rachana Mehta, Shubham Kumar, Ranjana SahClick on the article title to read more.
-
Response to Brönimann et al. 'The Challenges of Conducting a Surgical Trial – Reflectionson the EBRUC II Trial' BJU Int. (IF 3.7) Pub Date : 2025-05-27
Julian Peter Struck, Nadim Moharam, Mario W. Kramer -
Impact of concomitant carcinoma in situ distribution on non‐muscle‐invasive bladder cancer progression risk BJU Int. (IF 3.7) Pub Date : 2025-05-26
Jethro C.C. Kwong, Keiran Pace, Zizo Al‐Daqqaq, Yashan Chelliahpillai, Soomin Lee, Kellie Kim, Maximiliano Ringa, Amna Ali, Marian Wettstein, Amy Chan, Katherine Lajkosz, Theodorus van der Kwast, Nathan Perlis, Jason Y. Lee, Robert J. Hamilton, Neil E. Fleshner, Antonio Finelli, Munir Jamal, Frank Papanikolaou, Thomas Short, Andrew Feifer, Girish S. Kulkarni, Alexandre R. ZlottaObjectiveTo assess whether the distribution of concomitant carcinoma in situ (CIS; unifocal or multifocal) with papillary non‐muscle‐invasive bladder cancer (NMIBC) impacts the risk of progression, as concomitant CIS is an established risk factor for progression in papillary NMIBC and commonly used calculators do not make this distinction.Patients and MethodsIn this multi‐institutional retrospective
-
Robot‐assisted vs open kidney transplantation from deceased donors BJU Int. (IF 3.7) Pub Date : 2025-05-26
Luca Afferi, Angelo Territo, Alessio Pecoraro, Lorenzo Masieri, Milla Ortved, Julia Abildgaard Dagnæs‐Hansen, Begonya Etcheverry, Andrea Gallioli, Donato Cannoletta, Joris Vangeneugden, Jeremy Mercier, Thomas Prudhomme, Isacco Donnini, Antonino Vazzana, Malene Rohrsted, Francesc Vigués, Nicolas Doumerc, Karel Decaestecker, Joan Palou, Riccardo Campi, Sergio Serni, Andreas Roder, Alberto BredaObjectivesTo test the hypothesis that the type of surgical approach, robot‐assisted kidney transplantation (RAKT) vs open kidney transplantation (OKT), impacts intra‐operative and postoperative surgical outcomes of patients receiving kidney transplantation from deceased donors.Materials and MethodsThis was a multicentre retrospective cohort study including 676 patients who received RAKT or OKT in the
-
Establishing the role of single‐stage preputial spiral graft urethroplasty for panurethral stricture BJU Int. (IF 3.7) Pub Date : 2025-05-24
Marco Bandini, Pankaj Joshi, Sandeep Bafna, Christian Yepes, Ahmed Alrefaey, Mattia Longoni, Francesco Montorsi, Sanjay KulkarniObjectiveTo assess whether single‐stage preputial spiral graft urethroplasty (PSGU) minimises panurethral stricture (PUS) recurrence, which often result from traditional multiple grafting for anterior urethral strictures exceeding 10 cm.Patients and MethodsWe prospectively collected 114 patients with PUS treated with single‐stage PSGU across five centres in India, Colombia, Egypt, and Italy since May
-
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study BJU Int. (IF 3.7) Pub Date : 2025-05-24
Avani P. Desai, Ram Sankar Basak, Yair Lotan, John Sperger, Florian R. Schroeck, Robert Lipman, Iftach Chaplin, Hannah Roberson, Perla Lopez, Whitney Jenkins, John L. Gore, Michael R. Kosorok, Angela B. SmithObjectiveTo investigate the feasibility and effectiveness of interventions aiming to decrease pain and anxiety during cystoscopy.Patients and MethodsA prospective study of 190 adults undergoing flexible office cystoscopy was conducted at the University of North Carolina and the University of Texas Southwestern from January to September 2023. Patients were offered 20 mL intraurethral 2% lidocaine with
-
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study BJU Int. (IF 3.7) Pub Date : 2025-05-21
Mattia Longoni, Pietro Scilipoti, Mario De Angelis, Paolo Zaurito, Giovanni Tremolada, Alfonso Santangelo, Giuseppe Simone, Riccardo Mastroianni, Chiara Lonati, Stefania Zamboni, Nazareno Suardi, Gautier Marcq, Aleksandra Szostek, Jorge Caño Velasco, Alfonso Lafuente Puentedura, José Daniel Subiela, Pedro Del Olmo Durán, Aleksander Ślusarczyk, Pierre I. Karakiewicz, Benjamin Pradere, Francesco SoriaTo report real-world rates of non-muscle-invasive bladder cancer (NMIBC) recurrence and progression within a European multicentre cohort with detailed information on intravesical instillation courses, as contemporary data on oncological outcomes in NMIBC are limited.
-
Factors associated with Fournier's gangrene survival in a diverse urban community: a 15‐year review BJU Int. (IF 3.7) Pub Date : 2025-05-23
Jubin E. Matloubieh, Rutul D. Patel, Ethan Fram, Franklin C. LoweObjectiveTo assess risk factors, scoring systems, microbiology, and outcomes associated with Fournier's gangrene (FG) in a diverse urban community.MethodsA retrospective review of patients with FG medical data from 2007 to 2021 was performed. Means were compared via t‐tests, associations via chi‐square analysis, and survival probability via Kaplan–Meier analysis. Statistical findings were considered
-
A study of oral metformin for the intravesical treatment of non‐muscle‐invasive bladder cancer BJU Int. (IF 3.7) Pub Date : 2025-05-22
Jons W. van Hattum, Marinka J. Remmelink, Sieb T. Nuijens, Ben Max de Ruiter, Gerrit K.J. Hooijer, Jorg R. Oddens, C. Dilara Savci‐Heijink, Ron Mathot, J. Alfred Witjes, Michael .N. Pollak, Theo M. de Reijke, Remco J. Molenaar, Hanneke W. WilminkObjectivesTo evaluate the effect of metformin on non‐muscle‐invasive bladder cancer (NMIBC) marker lesions.Patients and methodsA phase II, open‐label, multicentre, marker lesion trial using oral metformin in patients with primary or recurrent, multiple, low‐grade Ta‐T1 NMIBC was conducted. After transurethral resection for histological confirmation, leaving one tumour as a marker lesion, 11 patients
-
Building foundations: implementing the ‘new’ boot camp model for first‐year urology residents in the UK BJU Int. (IF 3.7) Pub Date : 2025-05-22
Chandra Shekhar Biyani, Mamoun Hamid Elmamoun, Vishwanath HanchanaleClick on the article title to read more.
-
Enhancing urology theatre waste management: impact of a ‘Green Moment’ in daily surgical practice BJU Int. (IF 3.7) Pub Date : 2025-05-21
Fintan R. Ryan, Dearbhla Treacy, Diarmuid D. Sugrue, Rustom P. Manecksha, Robert J. Flynn, Arun Z. Thomas, Lisa G. Smyth, Eoin MacCraith, Rowan G. Casey, Clíodhna BrowneClimate change is poised to significantly impact public health in the coming years, both directly and indirectly. A 2023 report from The Lancet emphasised the gravity of this issue, identifying climate change as the greatest global health threat of the 21st century [1]. Paradoxically, the healthcare sector itself is a major contributor to climate change, whose global environmental impact ranges between
-
Current application of blockchain technology in healthcare and its potential roles in Urology BJU Int. (IF 3.7) Pub Date : 2025-05-21
Sulleyman Felemban, Ting Wai Yiu, Michael Harvey, Herman Lim, Jingge Zhu, Damien Bolton, Joseph IschiaObjectiveTo assess the current uses of blockchain technology in surgery and explore potential applications in urology.MethodsA systematic literature review and critical appraisal was performed. The PubMed database was searched for all relevant papers published in English, between 2003 and 2023, on blockchain and surgery, and urology.ResultsOur search yielded 59 results (35 eligible studies) for blockchain
-
Response to Białek et al. BJU Int. (IF 3.7) Pub Date : 2025-05-20
Chrystal Chang, David Barham, Faysal Yafi, Martin Gross, Jay SimhanClick on the article title to read more.
-
Response to Huang et al. BJU Int. (IF 3.7) Pub Date : 2025-05-20
Mohammed Lotfi AmerClick on the article title to read more.
-
A pilot study using ambient artificial intelligence scribes in clinical documentation in a urology outpatient clinic BJU Int. (IF 3.7) Pub Date : 2025-05-20
Julene Hui Wun Ong, Joshua Yi Min Tung, Gerald Gui Ren Sng, Daniel Yan Zheng Lim, Xinyan Yang, Iffat Bin Mohamad Rafi, Michelle Zhen Yuan Loke, Ajeet Kumar, Jonathan Yue En Tan, Eileen Yi Lee Lew, Mark Kok Hong Heng, Henry Sun Sien HoClick on the article title to read more.
-
Timing of urological management during post‐acute spinal cord injury rehabilitation BJU Int. (IF 3.7) Pub Date : 2025-05-20
Collene E. Anderson, Veronika Birkhäuser, Xavier Jordan, Martina D. Liechti, Eugenia Luca, Sandra Möhr, Jürgen Pannek, Thomas M. Kessler, Martin W.G. BrinkhofObjectivesTo provide a population‐based description of the timing and indicators of bladder storage medication and method of bladder emptying during post‐acute specialised spinal cord injury (SCI) rehabilitation.Patients and MethodsData from patients undergoing inpatient specialised post‐acute SCI rehabilitation were collected from 2013 to 2024 by the prospective, multicentre, longitudinal, Swiss Spinal
-
Percutaneous nephrolithotomy outcomes: papillary versus non‐papillary access and stone composition impact BJU Int. (IF 3.7) Pub Date : 2025-05-20
Sigen Huang, Jian Liu, Jianbin LuoClick on the article title to read more.
-
Robot‐assisted ureteric reconstruction BJU Int. (IF 3.7) Pub Date : 2025-05-19
Ailish Naughton, Barry B. McGuireClick on the article title to read more.
-
Bridging the gap: the role of large language model refinement in readability in urology research BJU Int. (IF 3.7) Pub Date : 2025-05-19
Giovanni E. Cacciamani, Ethan Layne, Maria Giovanna Asmundo, Giorgio Ivan RussoThe quality of scientific communication is crucial in ensuring that research findings are accessible and comprehensible to the intended audience. In fact, physicians and patients use internet very often in order to obtain and retrieve medical information [1, 2] and this highlight the importance of readability of research in order to maintain scientific accuracy. An important aspect of scientific publishing
-
Active surveillance in prostate cancer: when to exit and what are the options? BJU Int. (IF 3.7) Pub Date : 2025-05-19
Jianliang Liu, Dixon T.S. Woon, Marlon Perera, Nathan LawrentschukClick on the article title to read more.
-
Robot‐assisted PSMA‐radioguided surgery for local recurrence in the prostatic bed BJU Int. (IF 3.7) Pub Date : 2025-05-19
Fabian Falkenbach, Giovanni Mazzucato, Marie‐Lena Schmalhofer, Zhe Tian, Pierre I. Karakiewicz, Markus Graefen, Lars Budäus, Philipp Mandel, Fijs W.B. van Leeuwen, Matthias N. van Oosterom, Anne‐Claire Berrens, Henk G. van der Poel, Farzad Shenas, Daniel Koehler, Sophie Knipper, Tobias MaurerProstate-specific membrane antigen (PSMA)-imaging revealed evidence of locally confined relapses in one-quarter of patients with primary biochemical recurrence (BCR) after radical prostatectomy (RP) [1]. PSMA-targeted radioguided surgery (RGS) can facilitate precise removal of these lesions [2] as an alternative to salvage radiation therapy (RT). While open PSMA-RGS has demonstrated its potential for
-
What is lost in an average? Identifying distinct post-radical prostatectomy functional recovery profiles BJU Int. (IF 3.7) Pub Date : 2025-05-15
Patrick Lewicki, Kevin Ginsburg, Nnenaya Mmonu, Corinne Labardee, Anna Johnson, James Peabody, Adam Gadzinski, Alice Semerjian, Tudor Borza, Brian R. Lane, Andrew E. KrummTo describe, via latent variable mixture modelling, distinct post-radical prostatectomy (RP) patient-reported outcome (PRO) recovery profiles, which are positioned to complement currently disseminated statistical averages for shared decision-making.
-
Response to Lin et al. BJU Int. (IF 3.7) Pub Date : 2025-05-14
Victoria S. Edmonds, Mitchell R. HumphreysClick on the article title to read more.
-
Prostate cancer active surveillance in solid organ transplant: a matched study and literature review BJU Int. (IF 3.7) Pub Date : 2025-05-14
Mark N. Alshak, Michelle I. Higgins, Aurora J. Grutman, Jack Campbell, Joseph G. Cheaib, Carlos A. Rivera Lopez, Marcus Spann, Yuezhou Jing, Christian P. PavlovichObjectivesTo evaluate outcomes of prostate cancer (PCa) active surveillance (AS) in patients with versus without solid organ transplant (SOT), as the safety of PCa AS in patients with SOT remains understudied. We also performed a literature review to identify all studies describing PCa AS in patients with SOT.Patients and MethodsA retrospective study was conducted for patients with SOT (kidney, liver
-
Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normal BJU Int. (IF 3.7) Pub Date : 2025-05-14
Herbert Lepor, Jesse Persily, Samuel Parry, Eli Rapoport, Majlinda Tafa, James S. WysockObjectivesTo compare the clinically significant prostate cancer detection rate (csPCaDR) and pathological characteristics of magnetic resonance imaging (MRI) visible (MRIv) and MRI invisible (MRIi) cancers among men undergoing surveillance after ablative focal therapy (AFT) for intermediate‐risk PCa.Patients and MethodsA total of 305 five men enrolled in an Institutional Review Board‐approved primary
-
Re: metabolic syndrome and postoperative risks – a need for proactive BPH treatment BJU Int. (IF 3.7) Pub Date : 2025-05-14
Yu‐Hsiang Lin, Kuo‐Jen Lin, Hsin‐Ho LiuClick on the article title to read more.
-
Precision medicine in genitourinary oncology: are we pivoting towards imprecision? BJU Int. (IF 3.7) Pub Date : 2025-05-10
David J. Benjamin, Arash Rezazadeh KalebastyClick on the article title to read more.
-
Response to Chen et al. BJU Int. (IF 3.7) Pub Date : 2025-05-10
Nicolas A. Soputro, Jihad KaoukClick on the article title to read more.
-
Stone dust in endourology: a systematic review of its definition, management, and clinical impact BJU Int. (IF 3.7) Pub Date : 2025-05-09
Stefano Moretto, Alberto Quarà, Federico Zorzi, Alejandra Bravo‐Balado, Aideen Madden, Johan Cabrera, Mariela Corrales, Luigi Candela, Steeve Doizi, Frederic Panthier, Olivier TraxerObjectiveTo evaluate and synthesise the existing literature on stone dust (DUST) in endourology, focusing on its definition, creation methods, and removal techniques.MethodsA comprehensive electronic literature search was conducted using the PubMed/Medline, Web Of Science, and Embase databases to identify reports published until October 2024. The Preferred Reporting Items for Systematic Reviews and
-
Overcoming barriers in outpatient single‐port robot‐assisted laparoscopic radical prostatectomy: considerations for surgical and healthcare systems BJU Int. (IF 3.7) Pub Date : 2025-05-09
Shengyi Chen, Yuekun Fang, Bin ChengClick on the article title to read more.
-
Impact of β3‐adrenergic receptor agonist on kidney cancer risk in patients with overactive bladder BJU Int. (IF 3.7) Pub Date : 2025-05-09
Jee Soo Park, Soo Beom Choi, Jongchan Kim, Won Sik Jang, Won Sik HamObjectivesTo determine the effect of β3‐adrenergic receptor (AR) agonist on the risk of kidney cancer in patients with overactive bladder (OAB).Patients and methodsA nationwide population cohort study was conducted using data from the Korean National Health Insurance System database between January 2016 and December 2023. Validation analyses were performed using clinical data from patients with OAB
-
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients BJU Int. (IF 3.7) Pub Date : 2025-05-07
Jeffrey J. Leow, Santhosh Nagasubramanian, Zafer Tandogdu, Ashwin Sridhar, Prabhakar Rajan, Prasanna Sooriakumaran, Benjamin W. LambProstate cancer is the most prevalent non-skin solid malignancy among male renal transplant recipients. Curative treatment options for localised prostate cancer include robot-assisted radical prostatectomy (RARP) and radiotherapy. The largest multicentre study of transperitoneal RARP post-renal transplant included 41 men treated across four European centres between 2009 and 2019 [1]. While the standard
-
June's reviewers of the month BJU Int. (IF 3.7) Pub Date : 2025-05-06
Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.
-
-
What is chronic urinary tract infection? A systematic review BJU Int. (IF 3.7) Pub Date : 2025-05-06
Janni Søvsø Hjelmager, Karin Andersen, Thomas Emil Andersen, Kristian StærkTo define ‘chronic’ urinary tract infection (UTI) by reviewing current published research that employs this term.
-
Early postoperative visits improve outcomes in inguinal lymph node dissection for penile cancer BJU Int. (IF 3.7) Pub Date : 2025-05-02
Adnan Fazili, R. Barry Sirard, Zachary Thompson, Lexiaochuan Wen, Seyed Behzad Jazayeri, Cristina Naso, Christina Freamon, Jennifer Tighe, Jad Chahoud, Philippe E. SpiessObjectivesTo analyse postoperative outcomes after inguinal lymph node dissection (ILND) at a high‐volume North American centre for penile cancer with respect to early postoperative clinic visits facilitated by virtual telemedicine.MethodsData were retrospectively collected on patients undergoing ILND performed by a single surgeon between August 2006 and April 2024. The sample population was divided
-
Predictors of poor corporal integrity in penile implants: key insights and unanswered questions BJU Int. (IF 3.7) Pub Date : 2025-05-01
Łukasz Białek, Michał Skrzypczyk, Carlo BettocchiClick on the article title to read more.
-
Urinary retention after autologous fascial sling placement: a randomised trial comparing adjustment techniques BJU Int. (IF 3.7) Pub Date : 2025-04-30
Tiago Bortolini, Renan Timóteo de Oliveira, Aline Gularte Borges, Matheus Pinto La Maison, Nelson Sivonei da Silva Batezini, Marcio Augusto Averbeck, Tiago Elias RositoObjectiveTo evaluate the incidence of early postoperative urinary retention after autologous fascial sling (AFS) placement in women with stress urinary incontinence (SUI), comparing two graft adjustment techniques.Patients and MethodsThis randomised controlled trial enrolled 53 women with SUI, who were randomly assigned to undergo the retropubic sling procedure with one of two different AFS adjustment
-
Re‐defining the interpretation of 24‐h urine studies for stone formers BJU Int. (IF 3.7) Pub Date : 2025-04-30
Amnuay Kleebayoon, Viroj WiwanitkitClick on the article title to read more.
-
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’ BJU Int. (IF 3.7) Pub Date : 2025-04-29
Wilson Sui, Heiko Yang, Maria C. Velasquez, Marshall Stoller, Thomas ChiClick on the article title to read more.
-
-
Can only AI can save us from the burden of administration? BJU Int. (IF 3.7) Pub Date : 2025-04-28
Nathan Lawrentschuk -
Retrospective clinical and molecular characterisation of patients with penile intraepithelial neoplasia BJU Int. (IF 3.7) Pub Date : 2025-04-28
Sara Kaczor Elbæk, Philippe Lamy, Simen Laugesen, Christina Stilling, Iver Nordentoft, Lars Dyrskjøt, Jakob Kristian JakobsenObjectivesTo provide the first comprehensive molecular characterisation of penile intraepithelial neoplasia (PeIN) and to define the molecular alterations and clinical parameters associated with recurrence in order to enhance our ability to manage this disease.Patients and MethodsWe conducted a retrospective audit of records and an analysis of archived formalin‐fixed paraffin‐embedded (FFPE) tissue
-
Incidence, surveillance and natural history of high-grade prostatic epithelial neoplasia in the era of multiparametric MRI and targeted biopsy BJU Int. (IF 3.7) Pub Date : 2025-04-25
Nathalie Eid, Herbert LeporTo determine the incidence of isolated high grade prostatic epithelial neoplasia (iHGPIN) following magnetic resonance imaging (MRI)–ultrasonography co-registration fusion targeted biopsy (MRFTB) coupled with systematic biopsy (SB) and to assess the detection rates of clinically significant prostate cancer (csPCa).
-
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial BJU Int. (IF 3.7) Pub Date : 2025-04-25
Stephan Brönimann, Altug Tuncel, Rodolfo Hurle, David D'AndreaClick on the article title to read more.
-
A 360° multidisciplinary appraisal of novel surgical technologies – is this a new standard? BJU Int. (IF 3.7) Pub Date : 2025-04-25
Anthony Emmanuel, Sachin Malde, Prokar Dasgupta, Majed ShabbirClick on the article title to read more.
-
Challenges in assessing long‐term urinary and fecal outcomes following bladder exstrophy repair: Response to Liao et al. BJU Int. (IF 3.7) Pub Date : 2025-04-25
Abdellaoui Sarah, Cazzorla Fabiana, Morel‐Journel Nicolas, Bidault Valeska, Neuville Paul, Ruffion Alain, Pierre D.E. Mouriquand, Demède DelphineClick on the article title to read more.
-
Percentage of free to total PSA as a biomarker of survival in metastatic castration‐resistant prostate cancer BJU Int. (IF 3.7) Pub Date : 2025-04-25
Andrew W. Silagy, Dixon T.S. Woon, Louise Kostos, Rui Bernardino, Ting W. Yiu, Marian S. Wettstein, Hanan Goldberg, Jaime O. Herrera‐Cáceres, Hina Shiakh, Gregory Nason, Alexandre Zlotta, Eleftherios Diamantis, Damien Bolton, Neil FleshnerObjectiveTo analyse whether the percentage of free to total prostate‐specific antigen (%fPSA) is a prognostic biomarker in metastatic castration‐resistant prostate cancer (mCRPC), as novel studies suggest an elevated %fPSA is associated with adverse oncological outcomes for men with biochemical recurrence of prostate cancer.Patients and MethodsA biobank prospectively collated at mCRPC diagnosis was
-
Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups BJU Int. (IF 3.7) Pub Date : 2025-04-24
Anna Hagman, Anna Lantz, David Grannas, Stefan Carlsson, Olof Akre, Mats Olsson, Lars Egevad, Jonas Höijer, Peter WiklundTo evaluate the impact of a positive surgical margin (PSM) in relation to the risk of biochemical recurrence (BCR) and additional treatment in different preoperative Cancer of the Prostate Risk Assessment (CAPRA) risk groups after robot-assisted radical prostatectomy (RARP).